Figure 2.
Melatonin inhibits RANKL-induced osteoclastogenesis in Raw264.7 cells. Cathepsin K (A) mRNA and (B) protein expression in Raw264.7 cells cultured for 7 days with RANKL (100 ng/ml) and M-CSF (30 ng/ml) in the presence of varying concentrations (0.1 or 1 µmol) of melatonin. (C) Tartrate-resistant acid phosphatase activity in Raw264.7 cells cultured for 7 days with RANKL (100 ng/ml) and M-CSF (30 ng/ml) in the presence of varying concentrations (0.1 or 1 µmol) of melatonin. Magnification, ×200 (upper panels) and ×400 (bottom panels). (D) Viability of Raw264.7 cells in the presence of varying concentrations (0.1, 1 or 10 µmol) of melatonin. Cell viability was expressed as OD value. Data are represented as the mean ± SD (n=3). **P<0.01. OD, optical density; RANKL, receptor activator of nuclear factor-κB ligand; M-CSF, macrophage colony-stimulating factor.